2019
Predictors of timely opioid agonist treatment initiation among veterans with and without HIV
Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon K, Skanderson M, Barry DT, Crystal S, Justice A, Kraemer KL. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug And Alcohol Dependence 2019, 198: 70-75. PMID: 30878769, PMCID: PMC6836871, DOI: 10.1016/j.drugalcdep.2019.01.038.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyOpioid use disorderVeterans Aging Cohort StudyOAT initiationUninfected patientsClinical encountersNational observational cohortAging Cohort StudyAfrican American patientsImproved health outcomesAgonist therapyCohort studyObservational cohortTreatment initiationPredictive factorsEffective treatmentAdjusted modelUninfected controlsUse disordersPsychiatric diagnosisPWHClinical practicePatientsHealth outcomesRural residence
2004
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the Validity and Significance of Cannabis Withdrawal Syndrome. American Journal Of Psychiatry 2004, 161: 1967-1977. PMID: 15514394, DOI: 10.1176/appi.ajp.161.11.1967.Peer-Reviewed Original ResearchConceptsCannabis withdrawal syndromeWithdrawal syndromeClinical studiesSubstance withdrawal syndromeChronic heavy useAppetite changesCommon symptomsDiagnostic criteriaClinical importanceSyndromeHuman laboratoryPhysical discomfortWeight lossSymptomsBasic laboratoryTime courseAnimal laboratory researchDiscontinuationFindingsSeverity